Coface SA : Net income at €7.3m driven by an improvement

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
59
Coface SA : Net income at €7.3m driven by an improvement in net loss ratio / Fit to Win progressing as planned

Paris, 26 April 2017 - 17h35

Coface results for Q1-2017: Net income at €7.3m driven by an improvement in net loss ratio Fit to Win progressing as planned

  • Turnover reaches €348.3m down (2.2)% at constant FX and perimeter*
    • Mature markets stable
    • North America declining given the non-repeat of large deals signed in '16
    • Emerging markets are still impacted by the effect of risk action plans
  • Net loss ratio at 58.2%, net combined ratio at 92.0%
    • Gross loss ratio improved 4ppts. at 57.8% (vs 61.8% in Q4-16) driven by improvement in North America and Asia
    • Net loss ratio improved by 9.7ppts. vs. Q4-16 also reflecting increased recourse to reinsurance
    • Net cost ratio at 33.9%
  • Net income €7.3m
  • Fit to Win is progressing as planned
    • Roll out of risk action plan complete
    • Reached €2.0m cost savings year-to-date, in line with €10m objective for the year
  • Reminder of 2017 guidance: net loss ratio below 61% for the full year

Unless otherwise stated, changes are in comparison with 3M-2016 *Constant perimeter = excluding State Export Guarantees Management (€12.0m revenues in Q1-2016) Coface ceded this activity as from 1 January 2017 ; 2016 figures impacted by this activity have been restated so as to be comparable to 2017

Xavier Durand, CEO of Coface, commented:

"In a global economic environment where political risks remain high, the first quarter of 2017 continues to show the positive impacts of the Fit to Win plan: the actions taken to strengthen our risk infrastructure are now complete and starting to bear fruit. In Q1-17 we delivered a net profit of €7.3m thanks to a reduction in our loss ratio, in line with our guidance. The cost reductions are in line with expectations and we are making significant progress in the implementation of the operational efficiency programme, with additional impacts expected later in 2017. Turnover is still down but mature markets are now stabilizing, in part due to a good level of client activity and client retention. 2017 is a transition year, where we remain focused on the execution of our plan."

Key figures as at March 31 st 2017

The Board of Directors of Coface SA examined the summary consolidated financial statements for the first three months during its meeting on 26 April 2017. They were subject to review by the Audit Committee.

Income statement items - in €m Q1-2016 Q1-2016 ex. SEGM Q1-2017 V%* V%* ex. FX
Consolidated revenues 365.0 353.0 348.3 (1.3)% (2.2)%
of which gross earned premiums 288.5 288.5 282.2 (2.2)% (3.2)%
Underwriting income after reinsurance 26.5 20.8 14.5 (30.3)%  
Investment income net of expenses 10.8 10.8 5.6 (85.7)%  
Current operating income 37.3 31.6 20.1 (36.2)%  
Other operating income and expenses (1.0) (1.0) (1.0) (2.8)%  
Operating income 36.3 30.6 19.2 (37.3)%  
Net result (group share) 22.3 18.6 7.3 (60.6)% (60.1)%
Key ratios - in %          
Loss ratio net of reinsurance 55.0% 55.0% 58.2% +3.2 ppts.
Cost ratio net of reinsurance 32.0% 34.7% 33.9% (0.8) ppts.
Combined ratio net of reinsurance 87.0% 89.7% 92.0% +2.3 ppts.
           
  Balance sheet items - in €m 31/12/2016 31/12/2016 ex. SEGM 31/03/2017    
Equity (group share) 1755.2 1 751.5 1 770.4 +0.9%  
           
* V% : Variation Q1-2017 vs. Q1-2016 excluding State Export Guarantees Management (ex. SEGM) Ex. SEGM = excluding State Export Guarantees Management ; Coface ceded this activity as from 1 January 2017 2016 figures impacted by this activity have been restated so as to be comparable to 2017    
  1. Turnover

Coface registered a turnover of €348.3m for Q1-2017, down (1.3)% against Q1-2016 and (2.2)% ex. FX, all figures adjusted for the transfer of the French State export guarantee management which took place at the end of '16. This activity had no impact on the turnover in Q1-2017.

In Q1-2017 premiums have benefited from a pick-up in Coface's clients activity at +1.3%, a rebound that is seen in almost all markets. This was offset by a negative (1.4)% pricing impact (though improving from last year) as mature markets continue to see significant competitive pressure. Latin America continues to see a positive re-pricing.

In North America turnover is down by (11.3%) and (14.8%) at constant FX as Q1-2016 had benefited from several large deals that were not repeated this quarter.

In Central Europe, turnover was up 3.2% and 0.9% ex. FX, driven by continued good sales dynamism.

In the Mediterranean & Africa region, premiums grew by 2.6% ex. FX thanks to a continued good commercial momentum in the region.

Emerging markets had very different performances with Latin America growing at 14.4% (and 7.5% at constant FX) as the portfolio is benefiting from past price increases, whereas the impact of the risk action plans can be seen in Asia, where turnover is down by (13.0)% and (16.8)% ex. FX.

Business turnover in €m Q1-2016 Q1-2016 ex. SEGM Q1-2017 V%* V%* ex. FX  
Western Europe 84.4 72.4 73.1 +1.0% +2.6%  
Northern Europe 83.4 83.4 79.8 (4.3)% (4.3)%  
Mediterranean & Africa 84.6 84.6 86.8 +2.5% +2.6%  
North America 36.3 36.3 32.2 (11.3)% (14.8)%  
Central Europe 30.9 30.9 31.9 +3.2% +0.9%  
Asia-Pacific 26.9 26.9 23.4 (13.0)% (16.8)%  
Latin America 18.4 18.4 21.1 +14.4% +7.5%  
Consolidated business turnover 365.0 353.0 348.3 (1.3)% (2.2)%  
* V% : Variation Q1-2017 vs. Q1-2016 excluding State Export Guarantees Management (ex. SEGM) Ex. SEGM = excluding State Export Guarantees Management (€12.0m revenues in Q1-2016) Coface ceded this activity as from 1 January 2017 2016 figures impacted by this activity have been restated so as to be comparable to 2017          

New business production, at €39m, is down vs. Q1-2016. However, mature markets are at the same level as last year, the decline being driven by the risk action plans in emerging markets. Coface's client retention rate remains at a satisfactory 92.5%.

  1. Results
  • Combined ratio

The Group's net combined ratio stood at 92.0% for Q1-2017.

  1. Loss ratio

Gross loss ratio in Q1-17 stands at 57.8%, improving by 4ppts vs Q4-16. Compared to the gross loss ratio of FY-2016 (63.3%), the decline in loss ratio was mostly driven by North America, Asia and, to a lesser extend Latin America. The loss ratio in Asia is still at a high level though improving (128.5% vs. 146.8% for FY-16). The impact of the measures taken in 2015 and 2016 to reduce our risk exposures starts to materialize.

The Group's loss ratio after reinsurance was down (9.7) ppts. in Q1-2017, at 58.2% against 67.9% in Q4-2016. It has benefited from the decrease in gross loss ratio as well as the impact of the higher cession rate to reinsurers. It has also benefited from FX effect (for 2.1ppts.). Adjusted for this gain, the loss ratio would have been 60.3%.

Coface reminds its guidance of a net loss ratio below 61% for the full year 2017.

  1. Cost ratio

Coface continues to keep a good control on expenses. Fit to Win expense reductions reached €2.0m, in line with the annual target of €10m cost savings.

The Group's cost ratio after reinsurance stood at 33.9% for Q1-2017.

  • Financial income

Coface has maintained its prudent investment strategy and in particular took some additional protections ahead of key election in France. Excluding gains, revenues from the portfolio were flat at €9.8m, despite the continuous low rates environment. Net investment income reached €5.6m for the quarter, a sharp decline vs. Q1-2016 due to negative impact from FX variations, partially offsetting the FX gain seen on the loss ratio. The accounting yield [1] , excluding capital gains, was 0.4% for Q1-2017, at the same level as in Q1-2016.

  • Operating income and net income

Operating income stood at €19.2m at 31 March 2017, including €(0.6)m of investment and restructuring expenses related to Fit to Win .

Net income (group share) stood at €7.3m. Coface continued to suffer from a high tax rate of 52% due to the uneven profitability level between the various regions.

  1. Equity

At 31 March 2017, IFRS equity (group share) was €1,770.4m (up 0.9% vs FY-2016). The change in equity during the quarter is mainly the result of positive net income of €7.3m and a positive impact from FX movements for €5.9m.

  1. Outlook

Coface is totally focused on the execution of Fit to Win and the impacts of the initiatives we have now started to implement are expected to materialise gradually.

In 2017, our priority remains to execute our strategic plan while monitoring closely the development of the risk landscape. We remind that, in line with the first signs of improvement observed at this stage, we anticipate a net loss ratio below 61% in 2017. We expect to begin to benefit from the Fit to Win operational efficiency measures already taken and have planned to achieve €10m costs savings in 2017, while investments and restructuring charges for the year should amount to €21m.

Conference call with financial analysts

A conference call to discuss Coface Q1-2017 results with financial analysts will be held on 26 April 2017 at 6.00 pm Paris time. Dial in numbers: +33(0)1 70 77 09 46 (France), +44 (0)20 3043 2439 (UK), +1 646 722 49 08 (US). The presentation will be available at the following address: http://www.coface.com/Investors/Financial-reporting

Appendix

CONTACTS  
MEDIA   Monica COULL T. +33 (0)1 49 02 25 01 monica.coull@coface.com   Maria KRELLENSTEIN T. +33 (0)1 49 02 16 29 maria.krellenstein@coface.com     ANALYSTS / INVESTORS   Thomas JACQUET T. +33 (0)1 49 02 12 58 thomas.jacquet@coface.com   Cécile COMBEAU T. +33 (0)1 49 02 18 03 cecile.combeau@coface.com  

FINANCIAL CALENDAR 2017 (subject to change) Annual General Meeting: 17 May 2017 H1-2017 results: 28 July 2017, before market opening 9M-2017 results: 25 October 2017, after market close

FINANCIAL INFORMATION This press release, as well as Coface SA's integral regulatory information, can be found on the Group's website: http://www.coface.com/Investors

For regulated information on Alternative Performance Measures (APM), please refer to our 2016 Registration document.

About Coface   Coface, a world-leading credit insurer, offers 50,000 companies around the globe solutions to protect them against the risk of financial default of their clients, both on their domestic and export markets. The Group, which aims to be the most agile global credit insurer in the industry, is present in 100 countries, employs 4,300 people, and posted consolidated turnover of €1.411 billion in 2016.  Coface publishes quarterly country and sector risk assessments based on its unique knowledge of companies' payment behavior and on the expertise of its 660 underwriters and credit analysts located close to clients and their debtors. www.coface.com Coface SA. is listed on Euronext Paris - Compartment B ISIN: FR0010667147 / Ticker: COFA    

DISCLAIMER - Certain declarations featured in this press release may contain forecasts that notably relate to future events, trends, projects or targets. By nature, these forecasts include identified or unidentified risks and uncertainties, and may be affected by many factors likely to give rise to a significant discrepancy between the real results and those stated in these declarations. Please refer to the section 2.4 "Report from the Chairman of the Board of Directors on corporate governance, internal control and risk management procedures" as well as chapter 5 "Main risk factors and their management within the Group" of the Coface Group's 2016 Registration Document filed with AMF on 12 April 2017 under the number No. R.17-016 in order to obtain a description of certain major factors, risks and uncertainties likely to influence the Coface Group's businesses. The Coface Group disclaims any intention or obligation to publish an update of these forecasts, or provide new information on future events or any other circumstance. 

[1] Accounting profitability ratio calculated on average investment portfolio

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...326db3c0a8

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 105

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading

Top 5 Most Recently Viewed Articles

WTW's Strategic Acquisitions: A Leap into the Future of Insurance

Updated Category News Views 178

WTW Expands Through Innovative Acquisitions Willis Towers Watson Public Ltd., known as WTW, is making headlines with its ambitious strategy to enhance its technology-enabled insurance and workplace benefits services. By announcing two consequential acquisitions, WTW aims to broaden its reach in the middle market while modernizing its client interactions significantly....

Continue Reading
Microsoft Faces Competition After Downgrade from D.A. Davidson

Updated Category News Views 120

Microsoft's Recent Downgrade by Analysts Analysts at D.A. Davidson have made headlines by downgrading Microsoft's (NASDAQ: MSFT) rating from Buy to Neutral. They have kept a price target of $475, reflecting ongoing evaluations of Microsoft's market strategies and performance. Factors Contributing to the Downgrade A key reason for this downgrade is the increasing...

Continue Reading
Portman Ridge Finance Faces Market Challenges with PTMN Stock

Updated Category News Views 133

Portman Ridge Finance Corporation Stock Overview In the current economic landscape, Portman Ridge Finance Corporation (NASDAQ: PTMN) has seen its stock touch a 52-week low, now priced at $16.19. This significant drop highlights a shift in investor sentiment, with key indicators such as the Relative Strength Index (RSI) signaling that the stock may be oversold. Notably,...

Continue Reading
Miami International Holdings Sees Growth in July Trading

Updated Category News Views 135

Miami International Holdings Reports Trading Results Miami International Holdings, Inc., a technology-driven leader in financial markets, has announced significant trading results for July 2025. The company operates several exchanges, including MIAX, MIAX Pearl, MIAX Emerald, MIAX Sapphire, and MIAX Futures. These results demonstrate a capacity for growth and stability in...

Continue Reading
Intel's Game-Changing Innovations at CES 2025 Unveiled

Updated Category News Views 220

Unveiling Innovations at CES 2025 At a highly anticipated event in Las Vegas, Intel took the stage at CES 2025 to reveal its latest technological advancements in mobile computing and edge solutions. With the launch of the new Intel Core Ultra (Series 2) processors, Intel is set to lead the charge in revolutionizing the way businesses, creators, and gaming enthusiasts...

Continue Reading